Cutaneous Hyperaesthesia in SARS-CoV-2 Infection: Rare but not Unique Clinical Manifestation
DOI:
https://doi.org/10.2340/00015555-3729Keywords:
SARS-CoV2 infection, COVID-19, neurological symptomsAbstract
Abstract is missing (Short communication)
Downloads
References
Pascarella G, Strumia A, Piliego C, Bruno F, Del Buono R, Costa F, et al. COVID-19 diagnosis and management: a comprehensive review. J Intern Med 2020; 288: 192-206.
DOI: https://doi.org/10.1111/joim.13091
Mahase E. Covid-19: WHO declares pandemic because of "alarming levels" of spread, severity, and inaction. BMJ 2020; 368: m1036.
DOI: https://doi.org/10.1136/bmj.m1036
Esakandari H, Nabi-Afjadi M, Fakkari-Afjadi J, Farahmandian N, Miresmaeili SM, Bahreini E. A comprehensive review of COVID-19 characteristics. Biol Proced Online 2020; 22: 19.
DOI: https://doi.org/10.1186/s12575-020-00128-2
Ahmad I, Rathore FA. Neurological manifestations and complications of COVID-19: a literature review. J Clin Neurosci 2020; 77: 8-12.
DOI: https://doi.org/10.1016/j.jocn.2020.05.017
Helms J, Kremer S, Merdji H, Clere-Jehl R, Schenck M, Kummerlen C, et al. Neurologic features in severe SARS-CoV-2 infection. N Engl J Med 2020; 382: 2268-2270.
DOI: https://doi.org/10.1056/NEJMc2008597
Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol 2020; 77: 683-690.
DOI: https://doi.org/10.1001/jamaneurol.2020.1127
Liguori C, Pierantozzi M, Spanetta M, Sarmati L, Cesta N, Iannetta M, et al. Subjective neurological symptoms frequently occur in patients with SARS-CoV2 infection. Brain Behav Immun 2020; 88: 11-16.
DOI: https://doi.org/10.1016/j.bbi.2020.05.037
Merskey H, International Association for the Study of P, Task Force on T. Classification of chronic pain: descriptions of chronic pain syndromes and definitions of pain terms. Seattle: IASP; 2002.
Yamada K, Kubota Y, Shimizu Y, Cui R, Mori Y, Okuno Y, et al. Sleep shortage is associated with postherpetic neuralgia development through hyperesthesia and acute pain intensity: a community-based prospective cohort study. Pain Pract 2019; 19: 476-483.
DOI: https://doi.org/10.1111/papr.12766
Krajewski PK, Szepietowski JC, Maj J. Cutaneous hyperesthesia: a novel manifestation of COVID-19. Brain Behav Immun 2020; 87: 188.
DOI: https://doi.org/10.1016/j.bbi.2020.05.064
Moutal A, Martin LF, Boinon L, Gomez K, Ran D, Zhou Y, et al. SARS-CoV-2 spike protein co-opts VEGF-A/neuropilin-1 receptor signaling to induce analgesia. Pain 2020 Oct 1 [Online ahead of print].
DOI: https://doi.org/10.1097/j.pain.0000000000002097
Weekes CD, Beeram M, Tolcher AW, Papadopoulos KP, Gore L, Hegde P, et al. A phase I study of the human monoclonal anti-NRP1 antibody MNRP1685A in patients with advanced solid tumors. Invest New Drugs 2014; 32: 653-660.
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2021 Piotr K. Krajewski, Joanna Maj, Jacek C. Szepietowski
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (https://creativecommons.org/licenses/by-nc/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
